These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Isradipine treatment of hypertension in children: a single-center experience. Flynn JT; Warnick SJ Pediatr Nephrol; 2002 Sep; 17(9):748-53. PubMed ID: 12215829 [TBL] [Abstract][Full Text] [Related]
26. Sustained vasoconstriction associated with daily cyclosporine dose in heart and lung transplant recipients: potential pathophysiologic role of endothelin. Pei Y; Chan C; Cattran D; Cardella C; Zaltzman J; Lopez M; Tong J; Schachter R; Maurer J J Lab Clin Med; 1995 Jan; 125(1):113-9. PubMed ID: 7822939 [TBL] [Abstract][Full Text] [Related]
27. [Isradipine in arterial hypertension in motor vehicle drivers]. Aramisova RM; El'garov AA Med Tr Prom Ekol; 1996; (8):21-3. PubMed ID: 8963604 [TBL] [Abstract][Full Text] [Related]
28. Comparative effects of enalapril and nifedipine on renal hemodynamics in hypertensive renal allograft recipients. Abu-Romeh SH; el-Khatib D; Rashid A; Patel M; Osman N; Fayyad M; Scheikhoni A; Higazi AS Clin Nephrol; 1992 Apr; 37(4):183-8. PubMed ID: 1582056 [TBL] [Abstract][Full Text] [Related]
29. The role of dietary cations in the blood pressure of renal transplant recipients. Ramesh Prasad GV; Huang M; Nash MM; Zaltzman JS Clin Transplant; 2006; 20(1):37-42. PubMed ID: 16556151 [TBL] [Abstract][Full Text] [Related]
30. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism. Pessina AC; Ciccariello L; Perrone F; Stoico V; Gussoni G; Scotti A; Muggeo M Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914 [TBL] [Abstract][Full Text] [Related]
31. Lack of effect of the calcium antagonist isradipine on cyclosporine pharmacokinetics in renal transplant patients. Endresen L; Bergan S; Holdaas H; Pran T; Sinding-Larsen B; Berg KJ Ther Drug Monit; 1991 Nov; 13(6):490-5. PubMed ID: 1837629 [TBL] [Abstract][Full Text] [Related]
32. Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus. Bumbea V; Kamar N; Ribes D; Esposito L; Modesto A; Guitard J; Nasou G; Durand D; Rostaing L Nephrol Dial Transplant; 2005 Nov; 20(11):2517-23. PubMed ID: 15985508 [TBL] [Abstract][Full Text] [Related]
33. Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Iino Y; Hayashi M; Kawamura T; Shiigai T; Tomino Y; Yamada K; Kitajima T; Ideura T; Koyama A; Sugisaki T; Suzuki H; Umemura S; Kawaguchi Y; Uchida S; Kuwahara M; Yamazaki T; Clin Exp Nephrol; 2003 Sep; 7(3):221-30. PubMed ID: 14586719 [TBL] [Abstract][Full Text] [Related]
34. Cyclosporine dose reduction in stable renal transplant patients with high C2 level: simplified method of single C2 measurement and individualization of C0 target. Higgins RM; Kanji H; Hernon M; Harrison P; Lam FT; Kashi SH Transpl Int; 2005 Jul; 18(7):806-10. PubMed ID: 15948859 [TBL] [Abstract][Full Text] [Related]
35. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension. Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS; Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192 [TBL] [Abstract][Full Text] [Related]
36. Prophylactic isradipine treatment after kidney transplantation: a prospective double-blind placebo-controlled randomized trial. van den Dorpel MA; Zietse R; Ijzermans JN; Weimar W Transpl Int; 1994; 7 Suppl 1():S270-4. PubMed ID: 11271223 [TBL] [Abstract][Full Text] [Related]
37. Omega-3 fatty acids improve blood pressure control and preserve renal function in hypertensive heart transplant recipients. Holm T; Andreassen AK; Aukrust P; Andersen K; Geiran OR; Kjekshus J; Simonsen S; Gullestad L Eur Heart J; 2001 Mar; 22(5):428-36. PubMed ID: 11207085 [TBL] [Abstract][Full Text] [Related]
38. Vasoconstriction during acute hypervolemic hemodilution in hypertensive patients is not prevented by calcium blockade. Wysocki M; Andersson OK; Persson B; Bagge U Angiology; 1998 Jan; 49(1):41-8. PubMed ID: 9456163 [TBL] [Abstract][Full Text] [Related]
39. Renal function and blood pressure in heart transplant recipients treated with cyclosporine. Rottembourg J; Mattei MF; Cabrol A; Leger P; Aupetit B; Beaufils H; Gluckman JC; Pavie A; Gandjbakhch I; Cabrol C J Heart Transplant; 1985; 4(4):404-8. PubMed ID: 3916515 [TBL] [Abstract][Full Text] [Related]
40. Effect of clonidine therapy on renal hemodynamics in renal transplant hypertension. Green S; Zawada ET; Muakkassa W; Johnson M; Mackenzie T; McClanahan M; Graybill A; Goldman M Arch Intern Med; 1984 Jun; 144(6):1205-8. PubMed ID: 6375612 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]